These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26299812)

  • 21. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
    Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
    J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
    Liu J; Chi D; Lu H; Zhang T; Yamakawa T
    Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
    Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma.
    Li J; Gao H; Meng L; Yin L
    Tumour Biol; 2017 Jun; 39(6):1010428317708697. PubMed ID: 28631560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16 tumor suppressor therapy in salivary adenoid cystic carcinoma cell line SACC83.
    Zhang Y; Liu J; Xue F; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):70-4. PubMed ID: 15953919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RECK overexpression decreases invasive potential in prostate cancer cells.
    Rabien A; Ergün B; Erbersdobler A; Jung K; Stephan C
    Prostate; 2012 Jun; 72(9):948-54. PubMed ID: 22025325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RECK overexpression reduces invasive ability in ameloblastoma cells.
    Liang QX; Liang YC; Xu ZY; Chen WL; Xie HL; Zhang B
    J Oral Pathol Med; 2014 Sep; 43(8):613-8. PubMed ID: 24646032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest.
    Deng YT; Lin JK
    J Agric Food Chem; 2011 Dec; 59(24):13318-27. PubMed ID: 22082235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evolution pattern of the Runx3 gene 5'-CpG island methylation in human salivary gland adenoid cystic carcinoma].
    Tan Z; Ling ZQ; Chen C; Xu JJ; Ge MH
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):907-12. PubMed ID: 21223798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells.
    Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
    Toxicol Lett; 2011 Feb; 201(1):62-71. PubMed ID: 21167264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
    Sun L; Liu B; Lin Z; Yao Y; Chen Y; Li Y; Chen J; Yu D; Tang Z; Wang B; Zeng S; Fan S; Wang Y; Li Y; Song E; Li J
    Mol Cancer; 2015 Apr; 14():96. PubMed ID: 25924850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
    Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
    BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells.
    Sato A; Sekine M; Kobayashi M; Virgona N; Ota M; Yano T
    Chemotherapy; 2013; 59(3):192-9. PubMed ID: 24335094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on the inhibition of VEGF expression in salivary gland adenoid cystic carcinoma cells via iNOS gene RNAi in vitro.
    Ou Yang KX; Liang J; Yang ZN; Zhao JJ
    J Oral Pathol Med; 2015 Feb; 44(2):153-8. PubMed ID: 25065562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
    Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
    J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).
    Nagini S
    Anticancer Agents Med Chem; 2012 Sep; 12(7):718-25. PubMed ID: 22292753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.